Zhang, C., Slawek, D. E., Ross, J., Zolotov, Y., Castillo, F., Levin, F. R., Sohler, N. L., Minami, H., Cunningham, C. O., Starrels, J. L., & Arnsten, J. H. (2024). Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study. Cannabis and Cannabinoid Research, 9(3), e859–e869. https://doi.org/10.1089/can.2022.0248

Aron, J. A., Healy, E. W., Robinson, J. R. M., & Blinderman, C. D. (2024). Effects of Medical Cannabis Certification on Hospital Use by Individuals with Sickle Cell Disease. Cannabis and Cannabinoid Research, 9(2), 629–634. https://doi.org/10.1089/can.2022.0136

Hammond, C. J., Hyer, J. M., Boustead, A. E., Fristad, M. A., Steelesmith, D. L., Brock, G. N., Hasin, D. S., & Fontanella, C. A. (2024). Association Between Marijuana Laws and Suicide Among 12- to 25-Year-Olds in the United States From 2000 to 2019. Journal of the American Academy of Child & Adolescent Psychiatry, 63(3), 345–354. https://doi.org/10.1016/j.jaac.2023.06.014

Mauro, P. M., Gutkind, S., Askari, M. S., Hasin, D. S., Samples, H., Mauro, C. M., Annunziato, E. M., Boustead, A. E., & Martins, S. S. (2024). Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004–2019. Drug and Alcohol Dependence, 257, 111113. https://doi.org/10.1016/j.drugalcdep.2024.111113

Hasin, D. S., Wall, M. M., Alschuler, D. M., Mannes, Z. L., Malte, C., Olfson, M., Keyes, K. M., Gradus, J. L., Cerdá, M., Maynard, C. C., Keyhani, S., Martins, S. S., Fink, D. S., Livne, O., McDowell, Y., Sherman, S., & Saxon, A. J. (2023). Chronic pain, cannabis legalisation, and cannabis use disorder among patients in the US Veterans Health Administration system, 2005 to 2019: a repeated, cross-sectional study. The Lancet Psychiatry, 10(11), 877–886. https://doi.org/10.1016/s2215-0366(23)00268-7

Williams, A. R., Mauro, C. M., Feng, T., Waples, J., Martins, S. S., & Haney, M. (2023). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use. Cannabis and Cannabinoid Research, 8(5), 933–941. https://doi.org/10.1089/can.2021.0212

Hasin, D. S., Borodovsky, J., Shmulewitz, D., Walsh, C., Struble, C. A., Livne, O., Habib, M. I., Fink, D. S., Aharonovich, E., & Budney, A. (2023). Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. Addictive Behaviors, 140, 107617. https://doi.org/10.1016/j.addbeh.2023.107617

Gonçalves, P. D., Levy, N. S., Segura, L. E., Bruzelius, E., Boustead, A. E., Hasin, D. S., Mauro, P. M., & Martins, S. S. (2022). Cannabis Recreational Legalization and Prevalence of Simultaneous Cannabis and Alcohol Use in the United States. Journal of General Internal Medicine, 38(6), 1493–1500. https://doi.org/10.1007/s11606-022-07948-w

Weinberger, A. H., Wyka, K., Kim, J. H., Smart, R., Mangold, M., Schanzer, E., Wu, M., & Goodwin, R. D. (2022). A difference‐in‐difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004–17. Addiction, 117(6), 1768–1777. Portico. https://doi.org/10.1111/add.15795